mardi 19 septembre 2017

Onco Actu du 19 septembre 2017

4. Dépistage, diagnostic et pronostic

Whole-body scans benefit people with highest inherited cancer risk [Institute of Cancer Research]

Blood testing via sound waves may replace some tissue biopsies [MIT]

4.13 Dép., diag. & prono. - Peau

Testing metabolites in blood predicts success of skin cancer treatment [Institute of Cancer Research]

5.12.4 Immunothérapies - Essais

FDA slaps enrollment hold on 2 Tecentriq studies after Keytruda myeloma trial deaths [FiercePharma]

5.12.5 Immunothérapies - Pharma

Drugmakers Aim at Early Stage Cancer With Immunotherapy [Bloomberg]

5.2 Pharma

Phase III data showed that Venclexta/Venclyxto plus MabThera/Rituxan helped people with previously treated chronic lymphocytic leukaemia live longer without their disease worsening compared to bendamustine plus MabThera/Rituxan [Roche]

AbbVie and Roche tout a positive PhIII combo study of Venclexta, Rituxan in CLL — ahead of FDA pitch [EndPoints]

5.2.2 Pharma - Fusions & Acquisitions

So Much PARP Inhibitor Deal Hype, So Little Payoff [Bloomberg]

5.2.3 Pharma - économie

Biosimilar cancer drug threat closing in for Roche [Reuters]

FDA Clears Biotech Drug Copycats, But Buying Them Isn’t So Easy [Bloomberg]

5.3 Traitements - FDA, EMA, NICE...

Standing together: Supercharging the clinical trial in Europe [Pharmafile]

5.3.4 Traitements - AMM (FDA, EMA)

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome [Ipsen]

FDA Approves New Molecularly Targeted Therapeutic for Non-Hodgkin Lymphoma [Cancer Research Catalyst]

FDA Approves Inotuzumab for Adults with B-Cell Acute Lymphoblastic Leukemia [NCI]

6. Lutte contre les cancers

Peter Pisters officially named president of UT MD Anderson [university of Texas]

6.1 Observation

People with HIV who smoke are more likely to die from lung cancer than from HIV itself [Mass. General Hospital]

Smokers with HIV face higher risk from lung cancer than from AIDS [Reuters]

6.13 Soins palliatifs

End-of-life decisions can be difficult. This doctor thinks ‘nudges’ can help [STAT]